Pironetin

Name: Pironetin
Brand: MedChemExpress
SKU: HY-116446
Rating: 4.5 (0 reviews)

製品番号: HY-116446 純度: 96.79%: Data Sheet SDS COA 取扱説明書
FAQs
Technical Support

Pironetin is an α/β unsaturated lactone isolated from Streptomyces species. Pironetin binds to α-tubulin and is a potent inhibitor of microtubule polymerization, and has cell cycle arrest and antitumor activity.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

Pironetin 構造式

CAS 番号 : 151519-02-7

容量	価格（税別）	在庫状況	数量
500 μg	$474	在庫あり	Estimated Time of Arrival: December 31
1 mg	$787	在庫あり	Estimated Time of Arrival: December 31
5 mg	$2600	在庫あり	Estimated Time of Arrival: December 31
10 mg		お問い合わせ
50 mg		お問い合わせ

or バルクお問い合わせ

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 0 publication(s) in Google Scholar

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

生物活性
純度とドキュメンテーション
参考文献
カスタマーレビュー

製品説明

IC₅₀ & Target

Microtubule^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
A2780	GI₅₀	22.2 1 Compound: 1	Inhibition of tubulin alpha in human A2780 cells assessed as cell growth inhibition after 48 hrs by MTT assay Inhibition of tubulin alpha in human A2780 cells assessed as cell growth inhibition after 48 hrs by MTT assay	[PMID: 30693770]
A2780	IC₅₀	0.0029 3 Compound: Pironetin	Cytotoxicity against compound-sensitive human A2780 cells after 24 hrs by MTT assay Cytotoxicity against compound-sensitive human A2780 cells after 24 hrs by MTT assay	[PMID: 21396747]
A2780	IC₅₀	0.0029 3 Compound: Pironetin	Cytotoxicity against compound-sensitive human A2780 cells after 24 hrs by MTT assay Cytotoxicity against compound-sensitive human A2780 cells after 24 hrs by MTT assay	[PMID: 21396747]
A2780	IC₅₀	0.0029 3 Compound: Pironetin	Cytotoxicity against compound-sensitive human A2780 cells after 24 hrs by MTT assay Cytotoxicity against compound-sensitive human A2780 cells after 24 hrs by MTT assay	[PMID: 21396747]
A2780	IC₅₀	0.008 3 Compound: pironetin	Cytotoxicity against human A2780 cells after 24 hrs by MTT assay Cytotoxicity against human A2780 cells after 24 hrs by MTT assay	[PMID: 25426924]
A2780	IC₅₀	0.008 3 Compound: pironetin	Cytotoxicity against human A2780 cells after 24 hrs by MTT assay Cytotoxicity against human A2780 cells after 24 hrs by MTT assay	[PMID: 25426924]
A2780	IC₅₀	0.008 3 Compound: pironetin	Cytotoxicity against human A2780 cells after 24 hrs by MTT assay Cytotoxicity against human A2780 cells after 24 hrs by MTT assay	[PMID: 25426924]
A2780 ADR	IC₅₀	0.003 3 Compound: Pironetin	Cytotoxicity against compound-resistant human A2780AD cells after 24 hrs by MTT assay Cytotoxicity against compound-resistant human A2780AD cells after 24 hrs by MTT assay	[PMID: 21396747]
A2780	GI₅₀	22.2 1 Compound: 1	Inhibition of tubulin alpha in human A2780 cells assessed as cell growth inhibition after 48 hrs by MTT assay Inhibition of tubulin alpha in human A2780 cells assessed as cell growth inhibition after 48 hrs by MTT assay	[PMID: 30693770]
A2780 ADR	IC₅₀	0.025 3 Compound: pironetin	Cytotoxicity against human A2780AD cells after 24 hrs by MTT assay Cytotoxicity against human A2780AD cells after 24 hrs by MTT assay	[PMID: 25426924]
A2780	IC₅₀	26 1 Compound: 1	Inhibition of tubulin alpha in human A2780 cells assessed as reduction in cell growth Inhibition of tubulin alpha in human A2780 cells assessed as reduction in cell growth	[PMID: 30693770]
A2780 ADR	IC₅₀	0.003 3 Compound: Pironetin	Cytotoxicity against compound-resistant human A2780AD cells after 24 hrs by MTT assay Cytotoxicity against compound-resistant human A2780AD cells after 24 hrs by MTT assay	[PMID: 21396747]
MDA-MB-231	GI₅₀	4.6 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human MDA-MB-231 cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against human MDA-MB-231 cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
A2780 ADR	IC₅₀	0.003 3 Compound: Pironetin	Cytotoxicity against compound-resistant human A2780AD cells after 24 hrs by MTT assay Cytotoxicity against compound-resistant human A2780AD cells after 24 hrs by MTT assay	[PMID: 21396747]
A2780 ADR	IC₅₀	0.025 3 Compound: pironetin	Cytotoxicity against human A2780AD cells after 24 hrs by MTT assay Cytotoxicity against human A2780AD cells after 24 hrs by MTT assay	[PMID: 25426924]
A2780 ADR	IC₅₀	0.025 3 Compound: pironetin	Cytotoxicity against human A2780AD cells after 24 hrs by MTT assay Cytotoxicity against human A2780AD cells after 24 hrs by MTT assay	[PMID: 25426924]
MCF7	GI₅₀	5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human MCF7 cells assessed as reduction in growth after 3 days by MTT assay Cytotoxicity against human MCF7 cells assessed as reduction in growth after 3 days by MTT assay	[PMID: 31130264]
A549	GI₅₀	7.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human A549 cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against human A549 cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
DC3F	GI₅₀	9.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against hamster DC-3F cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against hamster DC-3F cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
HCT-15	IC₅₀	<0.015 3 Compound: Pironetin	Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
A549	GI₅₀	7.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human A549 cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against human A549 cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
A549	GI₅₀	7.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human A549 cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against human A549 cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
DC3F	GI₅₀	9.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against hamster DC-3F cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against hamster DC-3F cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
EL4	GI₅₀	15 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against C57BL/6 mouse EL4 cells assessed as reduction in growth after 3 days Cytotoxicity against C57BL/6 mouse EL4 cells assessed as reduction in growth after 3 days	[PMID: 31130264]
EL4	GI₅₀	15 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against C57BL/6 mouse EL4 cells assessed as reduction in growth after 3 days Cytotoxicity against C57BL/6 mouse EL4 cells assessed as reduction in growth after 3 days	[PMID: 31130264]
T98G	GI₅₀	7.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human T98G cells assessed as reduction in growth after 4 days by MTS assay Cytotoxicity against human T98G cells assessed as reduction in growth after 4 days by MTS assay	[PMID: 31130264]
HCT-15	IC₅₀	< 0.015 3 Compound: Pironetin	Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
HCT-15	IC₅₀	< 0.015 3 Compound: Pironetin	Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human HCT15 cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
DC3F	GI₅₀	9.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against hamster DC-3F cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against hamster DC-3F cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
HEK293	IC₅₀	0.017 3 Compound: pironetin	Cytotoxicity against human HEK293 cells after 3 days by MTT assay Cytotoxicity against human HEK293 cells after 3 days by MTT assay	[PMID: 25426924]
HEK293	IC₅₀	0.017 3 Compound: Pironetin	Cytotoxicity against HEK293 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against HEK293 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
HEK293	IC₅₀	0.017 3 Compound: Pironetin	Cytotoxicity against HEK293 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against HEK293 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
HEK293	IC₅₀	0.017 3 Compound: Pironetin	Cytotoxicity against HEK293 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against HEK293 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
HEK293	IC₅₀	0.017 3 Compound: pironetin	Cytotoxicity against human HEK293 cells after 3 days by MTT assay Cytotoxicity against human HEK293 cells after 3 days by MTT assay	[PMID: 25426924]
HeLa	IC₅₀	0.092 3 Compound: Pironetin	Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
HEK293	IC₅₀	0.017 3 Compound: pironetin	Cytotoxicity against human HEK293 cells after 3 days by MTT assay Cytotoxicity against human HEK293 cells after 3 days by MTT assay	[PMID: 25426924]
EL4	GI₅₀	15 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against C57BL/6 mouse EL4 cells assessed as reduction in growth after 3 days Cytotoxicity against C57BL/6 mouse EL4 cells assessed as reduction in growth after 3 days	[PMID: 31130264]
HL-60	GI₅₀	20 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human HL60 cells assessed as reduction in growth after 24 hrs by MTT assay Cytotoxicity against human HL60 cells assessed as reduction in growth after 24 hrs by MTT assay	[PMID: 31130264]
HL-60	GI₅₀	20 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human HL60 cells assessed as reduction in growth after 24 hrs by MTT assay Cytotoxicity against human HL60 cells assessed as reduction in growth after 24 hrs by MTT assay	[PMID: 31130264]
HT-29	IC₅₀	0.0064 3 Compound: pironetin	Cytotoxicity against human HT-29 cells after 3 days by MTT assay Cytotoxicity against human HT-29 cells after 3 days by MTT assay	[PMID: 25426924]
K562/Adr	GI₅₀	16 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human K562/ADR cells assessed as reduction in growth after 4 days by MTT assay Cytotoxicity against human K562/ADR cells assessed as reduction in growth after 4 days by MTT assay	[PMID: 31130264]
HeLa	IC₅₀	0.092 3 Compound: Pironetin	Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
HT-29	IC₅₀	0.0064 3 Compound: Pironetin	Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
K562	GI₅₀	17.3 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human K562 cells assessed as reduction in growth after 4 days by MTT assay Cytotoxicity against human K562 cells assessed as reduction in growth after 4 days by MTT assay	[PMID: 31130264]
K562	GI₅₀	17.3 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human K562 cells assessed as reduction in growth after 4 days by MTT assay Cytotoxicity against human K562 cells assessed as reduction in growth after 4 days by MTT assay	[PMID: 31130264]
NCI-H69	GI₅₀	17.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human H69 cells assessed as reduction in growth after 7 days by MTT assay Cytotoxicity against human H69 cells assessed as reduction in growth after 7 days by MTT assay	[PMID: 31130264]
K562/Adr	GI₅₀	16 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human K562/ADR cells assessed as reduction in growth after 4 days by MTT assay Cytotoxicity against human K562/ADR cells assessed as reduction in growth after 4 days by MTT assay	[PMID: 31130264]
HT-29	IC₅₀	0.0064 3 Compound: Pironetin	Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
HL-60	GI₅₀	20 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human HL60 cells assessed as reduction in growth after 24 hrs by MTT assay Cytotoxicity against human HL60 cells assessed as reduction in growth after 24 hrs by MTT assay	[PMID: 31130264]
MCF7	IC₅₀	0.006 3 Compound: pironetin	Cytotoxicity against human MCF7 cells after 3 days by MTT assay Cytotoxicity against human MCF7 cells after 3 days by MTT assay	[PMID: 25426924]
HT-29	IC₅₀	0.0064 3 Compound: pironetin	Cytotoxicity against human HT-29 cells after 3 days by MTT assay Cytotoxicity against human HT-29 cells after 3 days by MTT assay	[PMID: 25426924]
MCF7	IC₅₀	0.006 3 Compound: Pironetin	Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
A2780	GI₅₀	22.2 1 Compound: 1	Inhibition of tubulin alpha in human A2780 cells assessed as cell growth inhibition after 48 hrs by MTT assay Inhibition of tubulin alpha in human A2780 cells assessed as cell growth inhibition after 48 hrs by MTT assay	[PMID: 30693770]
HT-29	IC₅₀	0.0064 3 Compound: pironetin	Cytotoxicity against human HT-29 cells after 3 days by MTT assay Cytotoxicity against human HT-29 cells after 3 days by MTT assay	[PMID: 25426924]
HeLa	GI₅₀	30 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human HeLa cells assessed as reduction in growth Cytotoxicity against human HeLa cells assessed as reduction in growth	[PMID: 31130264]
MCF7	IC₅₀	0.015 3 Compound: Pironetin	Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
HT-29	IC₅₀	0.0064 3 Compound: Pironetin	Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
HeLa	IC₅₀	0.092 3 Compound: Pironetin	Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human HeLa cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
MCF7	GI₅₀	5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human MCF7 cells assessed as reduction in growth after 3 days by MTT assay Cytotoxicity against human MCF7 cells assessed as reduction in growth after 3 days by MTT assay	[PMID: 31130264]
K562	GI₅₀	17.3 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human K562 cells assessed as reduction in growth after 4 days by MTT assay Cytotoxicity against human K562 cells assessed as reduction in growth after 4 days by MTT assay	[PMID: 31130264]
MDA-MB-231	GI₅₀	4.6 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human MDA-MB-231 cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against human MDA-MB-231 cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
A2780	IC₅₀	26 1 Compound: 1	Inhibition of tubulin alpha in human A2780 cells assessed as reduction in cell growth Inhibition of tubulin alpha in human A2780 cells assessed as reduction in cell growth	[PMID: 30693770]
K562/Adr	GI₅₀	16 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human K562/ADR cells assessed as reduction in growth after 4 days by MTT assay Cytotoxicity against human K562/ADR cells assessed as reduction in growth after 4 days by MTT assay	[PMID: 31130264]
NCI-H69	GI₅₀	17.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human H69 cells assessed as reduction in growth after 7 days by MTT assay Cytotoxicity against human H69 cells assessed as reduction in growth after 7 days by MTT assay	[PMID: 31130264]
HeLa	GI₅₀	30 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human HeLa cells assessed as reduction in growth Cytotoxicity against human HeLa cells assessed as reduction in growth	[PMID: 31130264]
MCF7	GI₅₀	5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human MCF7 cells assessed as reduction in growth after 3 days by MTT assay Cytotoxicity against human MCF7 cells assessed as reduction in growth after 3 days by MTT assay	[PMID: 31130264]
P388	GI₅₀	100 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against mouse P388 cells assessed as reduction in growth after 24 hrs by MTT assay Cytotoxicity against mouse P388 cells assessed as reduction in growth after 24 hrs by MTT assay	[PMID: 31130264]
MCF7	IC₅₀	0.006 3 Compound: pironetin	Cytotoxicity against human MCF7 cells after 3 days by MTT assay Cytotoxicity against human MCF7 cells after 3 days by MTT assay	[PMID: 25426924]
MCF7	IC₅₀	0.015 3 Compound: Pironetin	Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
T98G	GI₅₀	7.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human T98G cells assessed as reduction in growth after 4 days by MTS assay Cytotoxicity against human T98G cells assessed as reduction in growth after 4 days by MTS assay	[PMID: 31130264]
MCF7	IC₅₀	0.006 3 Compound: Pironetin	Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
MCF7	IC₅₀	0.006 3 Compound: Pironetin	Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth after 72 hrs by MTT assay	[PMID: 25240870]
MCF7	IC₅₀	0.006 3 Compound: pironetin	Cytotoxicity against human MCF7 cells after 3 days by MTT assay Cytotoxicity against human MCF7 cells after 3 days by MTT assay	[PMID: 25426924]
P388	GI₅₀	100 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against mouse P388 cells assessed as reduction in growth after 24 hrs by MTT assay Cytotoxicity against mouse P388 cells assessed as reduction in growth after 24 hrs by MTT assay	[PMID: 31130264]
MCF7	IC₅₀	0.015 3 Compound: Pironetin	Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay Cytotoxicity against human MCF7 cells after 48 hrs by sulforhodamine B assay	[PMID: 30601004]
MDA-MB-231	GI₅₀	4.6 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human MDA-MB-231 cells assessed as reduction in growth after 4 days by HCS assay Cytotoxicity against human MDA-MB-231 cells assessed as reduction in growth after 4 days by HCS assay	[PMID: 31130264]
NCI-H69	GI₅₀	17.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human H69 cells assessed as reduction in growth after 7 days by MTT assay Cytotoxicity against human H69 cells assessed as reduction in growth after 7 days by MTT assay	[PMID: 31130264]
P388	GI₅₀	100 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against mouse P388 cells assessed as reduction in growth after 24 hrs by MTT assay Cytotoxicity against mouse P388 cells assessed as reduction in growth after 24 hrs by MTT assay	[PMID: 31130264]
T98G	GI₅₀	7.5 1 Compound: 1; (-)-PA-48153C	Cytotoxicity against human T98G cells assessed as reduction in growth after 4 days by MTS assay Cytotoxicity against human T98G cells assessed as reduction in growth after 4 days by MTS assay	[PMID: 31130264]

体外実験

Pironetin (20-100 ng/mL; 24 hours; 3Y1 cells) treatment arrests the cell cycle progression at G2/M in 3Y1 cells^[1].
Pironetin (1-10000 ng/mL; 3 days; HeLa, A2780 and K-NRK cells) treatment inhibits the cell proliferation. IC₅₀ values against these cell lines are almost 10 ng/mL^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cycle Analysis^[1]

Cell Line:	3Y1 cells
Concentration:	20 ng/mL, 50 ng/mL, 100 ng/mL
Incubation Time:	24 hours
Result:	Arrested the cell cycle progression at G2/M in3Y1 cells.

Cell Proliferation Assay^[1]

Cell Line:	HeLa, A2780 and K-NRK cells
Concentration:	1 ng/mL, 10 ng/mL, 100 ng/mL, 1000 ng/mL and 10000 ng/mL
Incubation Time:	3 days
Result:	Inhibited the cell proliferation.

体内実験

Pironetin (0.78-6.25 mg/kg; intraperitoneal injection; daily; for 5 days; female CDF1-SLC mice) treatment shows a moderate antitumor effect, however, a severe weight loss is observed as a side effect^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	Female CDF1-SLC mice (10 weeks) injected with P388 murine leukemia cells^[1]
Dosage:	0.78 mg/kg, 1.56 mg/kg, 3.13 mg/kg, 6.25 mg/kg
Administration:	Intraperitoneal injection; daily; for 5 days
Result:	Showed a moderate antitumor effect.

分子量

324.45

分子式

C₁₉H₃₂O₄

CAS 番号

151519-02-7

Appearance

Oil

Color

Colorless to off-white

SMILES

O=C1C=C[C@H]([C@H](O1)C[C@H]([C@@H]([C@@H]([C@H](C/C=C/C)C)OC)C)O)CC

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

Pure form	-20°C	3 years
In solvent	-80°C	6 months
	-20°C	1 month

溶剤 & 溶解度

体外:

DMSO : < 1 mg/mL (insoluble or slightly soluble)

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）

体積 _（開始）

濃度 _（終了）

体積 _（終了）

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

純度とドキュメンテーション

純度: 96.79%

Select Batch:

データシート (270 KB) SDS (252 KB)

COA (245 KB) LCMS (100 KB)

取扱説明書 (2659 KB)

参考文献

[1]. Kondoh M, et al. Cell cycle arrest and antitumor activity of pironetin and its derivatives. Cancer Lett. 1998 Apr 10;126(1):29-32. [Content Brief]

[2]. Yang J, et al. Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule. ] Nat Commun. 2016 Jun 30;7:12103. [Content Brief]

Pironetin Related Classifications

Molarity Calculator
Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量		濃度		体積		分子量 *
	=		×		×

The dilution calculator equation

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

一般には略語で表示されます：C₁V₁ = C₂V₂

濃度 _（開始）	×	体積 _（開始）	=	濃度 _（終了）	×	体積 _（終了）
	×		=		×
C1		V1		C2		V2

Help & FAQs

Do most proteins show cross-species activity?
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Pironetin151519-02-7Microtubule/TubulinInhibitorinhibitorinhibit

日本の代理先をお選びくださいナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
製品名			カスタマ需要量 *
お名前 *			タイトル
メールアドレス *			電話番号 *
デパートメント			組纖名 *
市区町村			都道府県
国或いは地域 *
必ず会社名を記載ください。個人への返信は行いません。
備考

製品名			Lot #
お名前 *			メールアドレス *
電話番号 *			部門 *
組纖名 *			国或いは地域 *
備考

お名前
メール *

	Sorry, but the email address you supplied was invalid.

Pironetin

カスタマーレビュー

Pironetin 関連抗体

おすすめ

•関連スクリーニングライブラリ:

•関連小分子:

•関連タンパク質:

生物活性

純度とドキュメンテーション

参考文献

カスタマーレビュー

Pironetin 関連抗体

Molarity Calculator

Dilution Calculator

Pironetin Related Classifications

Molarity Calculator

Dilution Calculator

The molarity calculator equation

The dilution calculator equation

Keywords:

最近チェックした製品:

カスタマーレビュー

Request for HNMR Report

Request for HNMR Report